Stock listing
BOATS:ANTX AN2 Therapeutics, Inc. Stock
US listing (BOATS) of AN2 Therapeutics, Inc. · home listing NASDAQ:ANTX
Follow AN2 Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:ANTX
$4.53 USD -0.16 (-3.4%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ANTX
- Day range
- $4.31 – $4.76 USDOct 30, 2026
- Volume
- 284,722 sharesOct 30, 2026
- Market cap
- $170.9M USDAt the close on Oct 30, 2026 · price × 37.74M shares outstanding
- 52-week range
- $1.00 – $7.19 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $1.35M USDMedian day 240,245 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ANTX · Home | $4.53 USD | -0.16 (-3.4%) | 284,722 | $4.66 | $4.76 | $4.31 | $4.69 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:ANTX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $4.53 | -0.16 | -3.4% | $4.66 | $4.76 | $4.31 | 284,722 | |
| $4.69 | +0.17 | +3.8% | $4.57 | $4.90 | $4.53 | 555,792 | |
| $4.52 | +0.66 | +17.1% | $3.86 | $4.60 | $3.85 | 545,417 | |
| $3.86 | +0.23 | +6.3% | $3.61 | $3.89 | $3.54 | 239,623 | |
| $3.63 | +0.08 | +2.3% | $3.55 | $3.70 | $3.50 | 196,183 | |
| $3.55 | -0.09 | -2.5% | $3.61 | $3.66 | $3.47 | 124,439 | |
| $3.64 | +0.04 | +1.1% | $3.57 | $3.72 | $3.521 | 95,191 | |
| $3.60 | +0.04 | +1.1% | $3.58 | $3.78 | $3.57 | 177,367 | |
| $3.56 | +0.19 | +5.6% | $3.38 | $3.59 | $3.36 | 129,744 | |
| $3.37 | -0.01 | -0.3% | $3.39 | $3.46 | $3.21 | 330,870 | |
| $3.38 | -0.22 | -6.1% | $3.60 | $3.62 | $3.30 | 281,730 | |
| $3.60 | +0.06 | +1.7% | $3.50 | $3.69 | $3.50 | 295,943 | |
| $3.54 | -0.06 | -1.7% | $3.55 | $3.73 | $3.33 | 431,025 | |
| $3.60 | -0.70 | -16.3% | $4.30 | $4.32 | $3.59 | 515,050 | |
| $4.30 | -0.10 | -2.3% | $4.41 | $4.41 | $4.24 | 298,465 | |
| $4.40 | -0.28 | -6.0% | $4.65 | $4.67 | $4.26 | 442,134 | |
| $4.68 | -0.17 | -3.5% | $4.77 | $4.86 | $4.43 | 427,826 | |
| $4.85 | -0.22 | -4.3% | $5.02 | $5.06 | $4.695 | 365,253 | |
| $5.07 | -0.54 | -9.6% | $5.39 | $5.60 | $5.005 | 318,215 | |
| $5.61 | -0.10 | -1.8% | $5.69 | $5.86 | $5.50 | 299,949 | |
| $5.71 | +0.09 | +1.6% | $5.64 | $5.99 | $5.51 | 451,333 | |
| $5.62 | +0.30 | +5.6% | $5.29 | $5.73 | $5.155 | 509,439 | |
| $5.32 | +0.23 | +4.5% | $5.07 | $5.35 | $5.00 | 199,204 | |
| $5.09 | +0.08 | +1.6% | $4.99 | $5.20 | $4.76 | 178,839 | |
| $5.01 | +0.13 | +2.7% | $4.89 | $5.17 | $4.67 | 318,456 | |
| $4.88 | -0.01 | -0.2% | $4.91 | $4.95 | $4.71 | 155,127 | |
| $4.89 | +0.06 | +1.2% | $4.77 | $5.06 | $4.72 | 258,937 | |
| $4.83 | 0.00 | 0.0% | $4.86 | $4.95 | $4.67 | 306,158 | |
| $4.83 | -0.13 | -2.6% | $5.00 | $5.05 | $4.70 | 191,680 | |
| $4.96 | -0.09 | -1.8% | $5.06 | $5.25 | $4.92 | 305,221 | |
| $5.05 | +0.15 | +3.1% | $4.89 | $5.15 | $4.80 | 670,954 | |
| $4.90 | -0.44 | -8.2% | $5.39 | $5.47 | $4.88 | 204,494 | |
| $5.34 | -0.02 | -0.4% | $5.38 | $5.44 | $5.295 | 146,046 | |
| $5.36 | -0.10 | -1.8% | $5.43 | $5.50 | $5.20 | 156,797 | |
| $5.46 | +0.05 | +0.9% | $5.43 | $5.645 | $5.34 | 221,486 | |
| $5.41 | -0.28 | -4.9% | $5.70 | $5.78 | $5.40 | 103,538 | |
| $5.69 | -0.04 | -0.7% | $5.56 | $5.88 | $5.54 | 222,312 | |
| $5.73 | -0.25 | -4.2% | $5.98 | $6.125 | $5.605 | 175,804 | |
| $5.98 | +0.09 | +1.5% | $6.00 | $6.06 | $5.76 | 335,287 | |
| $5.89 | -0.06 | -1.0% | $5.97 | $6.06 | $5.85 | 77,182 | |
| $5.95 | 0.00 | 0.0% | $6.05 | $6.20 | $5.79 | 199,660 | |
| $5.95 | +0.47 | +8.6% | $5.46 | $6.00 | $5.46 | 353,561 | |
| $5.48 | -0.07 | -1.3% | $5.53 | $5.67 | $5.40 | 215,423 | |
| $5.55 | -0.03 | -0.5% | $5.58 | $5.645 | $5.40 | 124,021 | |
| $5.58 | -0.16 | -2.8% | $5.67 | $5.78 | $5.40 | 240,866 | |
| $5.74 | +0.21 | +3.8% | $5.46 | $5.79 | $5.46 | 204,041 | |
| $5.53 | -0.13 | -2.3% | $5.66 | $5.85 | $5.50 | 287,524 | |
| $5.66 | +0.03 | +0.5% | $5.67 | $5.80 | $5.60 | 217,706 | |
| $5.63 | -0.18 | -3.1% | $5.82 | $5.82 | $5.59 | 171,420 | |
| $5.81 | +0.02 | +0.3% | $5.84 | $5.89 | $5.50 | 225,449 | |
| $5.79 | -0.17 | -2.9% | $5.98 | $6.13 | $5.72 | 195,335 | |
| $5.96 | -0.01 | -0.2% | $5.97 | $6.045 | $5.775 | 266,091 | |
| $5.97 | +0.24 | +4.2% | $5.59 | $5.995 | $5.58 | 215,701 | |
| $5.73 | -0.26 | -4.3% | $5.96 | $6.21 | $5.725 | 273,765 | |
| $5.99 | +0.01 | +0.2% | $6.04 | $6.205 | $5.94 | 198,352 | |
| $5.98 | -0.30 | -4.8% | $6.28 | $6.365 | $5.90 | 298,934 | |
| $6.28 | +0.41 | +7.0% | $6.09 | $7.19 | $5.66 | 429,196 | |
| $5.87 | -0.04 | -0.7% | $5.92 | $6.09 | $5.80 | 68,726 | |
| $5.91 | -0.02 | -0.3% | $5.91 | $6.08 | $5.69 | 91,246 | |
| $5.93 | -0.15 | -2.5% | $6.12 | $6.17 | $5.775 | 124,474 | |
| $6.08 | +0.24 | +4.1% | $5.82 | $6.26 | $5.81 | 207,261 | |
| $5.84 | -0.10 | -1.7% | $5.94 | $5.99 | $5.71 | 145,950 | |
| $5.94 | +0.36 | +6.5% | $5.65 | $6.145 | $5.52 | 368,377 | |
| $5.58 | +0.23 | +4.3% | $5.39 | $5.65 | $5.35 | 305,993 | |
| $5.35 | +0.02 | +0.4% | $5.37 | $5.66 | $5.26 | 250,627 | |
| $5.33 | +0.31 | +6.2% | $5.03 | $5.60 | $5.03 | 358,501 |
- Ticker
- BOATS:ANTX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 23, 2026
AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(c)(4)
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 50 slides
Latest news
AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(c)(4)
Oct 23, 2026
Closed $3.63 (+2.3%) on Oct 26, 2026
AN2 Therapeutics to Present Phase 2 Design for Epetraborole in Polycythemia Vera at the 18th International Congress on Myeloproliferative Neoplasms
Oct 21, 2026
Closed $3.60 (+1.1%) on Oct 21, 2026
AN2 Therapeutics to Participate at Upcoming Investor Conferences
Oct 20, 2026
Closed $3.60 (+1.1%) on Oct 21, 2026
AN2 Therapeutics Announces Extension of Funding for Tuberculosis Research Collaboration with GSK
Sep 28, 2026
Closed $5.01 (+2.7%) on Sep 28, 2026
AN2 Therapeutics Presents Clinical and Translational Data Supporting Development of Epetraborole for Polycythemia Vera at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting
Aug 31, 2026
Closed $5.48 (-1.3%) on Sep 1, 2026
AN2 Therapeutics Appoints Cameron Trenor, M.D., as Chief Medical Officer
Aug 24, 2026
Closed $5.63 (-3.1%) on Aug 24, 2026
AN2 Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business and Scientific Highlights
Aug 11, 2026
Closed $6.28 (+7.0%) on Aug 12, 2026
AN2 Therapeutics Reports Positive Enabling Data Supporting Advancement of Oral AN2-502998 to Phase 2 Study for Chronic Chagas Disease
Jun 4, 2026
Closed $4.17 (-0.7%) on Jun 4, 2026
AN2 Therapeutics to Present at 2026 Jefferies Global Healthcare Conference
May 21, 2026
Closed $4.89 (+6.5%) on May 21, 2026
AN2 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business and Scientific Highlights
May 11, 2026
Closed $4.27 (-9.5%) on May 12, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 50 slides · September 2026
Corporate Update (March 2026)
Corporate update · 17 slides · Mar 4, 2026
Investor Presentation (June 2025)
Investor deck · 40 slides · Jun 11, 2025
AN2 Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 21 in the last 12 months · 57 in all · newest Oct 23, 2026 · oldest 2022
- Decks
- 3 decks · latest September 2026
Where AN2 Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ANTX · Home listing | NASDAQ | United States | USD |
| BOATS:ANTX · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about AN2 Therapeutics, Inc.